コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 by pretreatment of monocytes with Ab against P-selectin glycoprotein ligand 1.
2 nase B (Akt) and dependent on P-selectin and P-selectin glycoprotein ligand 1.
3 ted when the bacterium engaged its receptor, P-selectin glycoprotein ligand 1.
4 ockade of P-selectin or its leukocyte ligand P-selectin glycoprotein ligand-1.
5 d by monoclonal antibodies to L-selectin and P-selectin glycoprotein ligand-1.
6 C(high) monocytes to the CNS is regulated by P-selectin glycoprotein ligand-1.
7 ce deficient in the major P-selectin ligand, P-selectin glycoprotein ligand-1.
9 f initial treatment with the soluble form of P-selectin glycoprotein ligand-1, a soluble ligand for P
11 d and rejected grafts express high levels of P-selectin glycoprotein ligand 1 and glycosylated CD43.
12 edominant E-selectin ligands on NK cells are P-selectin glycoprotein ligand-1 and protease-resistant
13 heres (MSs) were conjugated with recombinant P-selectin glycoprotein ligand-1 and systemically inject
14 uding CD43, CD44, CD45, CD93, CD162 (PSGL-1; P-selectin glycoprotein ligand 1), and the surface-attac
15 s in the mucins, MUC2, MUC20, MUC21, protein P-selectin-glycoprotein ligand 1, and proteoglycan synde
16 E-selectin-mediated migration of Tc1 cells, P-selectin glycoprotein ligand-1 appears to be the sole
17 These results indicate that P-selectin and P-selectin glycoprotein ligand-1 are not required for le
19 at utilizes sialyl Lewis x (sLe(x))-modified P-selectin glycoprotein ligand 1 as a receptor for infec
20 or with a supporting role for the P-selectin/P-selectin glycoprotein ligand 1 axis, followed by (2) f
21 ltransferases, C2GnT (Core2 transferase), or P-selectin glycoprotein ligand-1 between HL60var and typ
22 irectly shown to contribute to high-affinity P-selectin glycoprotein ligand-1 binding by P-selectin.
23 played on O-linked glycans, akin to those on P-selectin glycoprotein ligand-1, but distinct from the
24 e reduced tethering to the L-selectin ligand P-selectin glycoprotein ligand-1, but rolling velocity o
25 ectin-bearing microspheres or neutrophils on P-selectin glycoprotein ligand-1 by force decreased bond
27 tethering of these microspheres or cells to P-selectin glycoprotein ligand-1 by three transport mech
28 trafficking, and P-selectin and its ligand, P-selectin glycoprotein ligand-1, can modulate hemostasi
29 on an array of protein scaffolds, including P-selectin glycoprotein ligand-1, CD43, and CD44 (render
30 ther administration of a soluble recombinant P-selectin glycoprotein ligand-1 chimera (rPSGL-Ig) in c
31 significantly higher numbers of recombinant P-selectin glycoprotein ligand-1-conjugated MSs adhered
32 m-diameter microspheres with the recombinant P-selectin glycoprotein ligand-1 construct 19.ek.Fc.
33 O treatment reduced intragraft expression of P-selectin glycoprotein ligand-1, CX(3)CL1, CCL19, CCL20
34 pus was induced in female wild-type (WT) and P-selectin glycoprotein ligand-1 deficient (Psgl-1(-/-))
36 neutrophils roll over FLIPRs in a P-selectin/P-selectin glycoprotein ligand-1-dependent manner, retri
38 /hematopoietic cell E-/L-selectin ligand and P-selectin glycoprotein ligand-1) from hematopoietic cel
39 og of the naturally occurring binding ligand P-selectin glycoprotein ligand 1 fused to a human fragme
40 which contained two E-selectin ligands, the P-selectin glycoprotein ligand-1 glycoform "CLA," and CD
41 ty regulates thrombosis in a P-selectin- and P-selectin glycoprotein ligand-1-independent manner and
42 f infection and is mediated by chemokine- or P-selectin glycoprotein ligand-1-induced inside-out sign
43 D49d and CD49e, as well as to P-selectin and P-selectin glycoprotein ligand 1, inhibited basophil rol
44 vealed that CLP-2 homing involves P-selectin/P-selectin glycoprotein ligand 1 interactions, pertussis
47 n-associated antigen-1 activation that links P-selectin glycoprotein ligand-1 ligation to integrin ac
48 tern to LNs, neutrophils used L-selectin and P-selectin glycoprotein ligand-1, macrophage-1 Ag and LF
50 eefold increase in O-linked glycosylation of P-selectin glycoprotein ligand-1 on the surface of leuko
51 rvival times of P-selectin dissociating from P-selectin glycoprotein ligand 1 or from an antibody in
52 ls through engagement of the selectin ligand P-selectin glycoprotein ligand-1 or the chemokine recept
53 urements of L- and P-selectin complexed with P-selectin glycoprotein ligand-1 or their respective ant
54 r BAY11-7082, antibodies neutralizing CD162 (P-selectin glycoprotein ligand-1) or VWF, or arginylglyc
57 teraction between P-selectin and its ligand (P-selectin glycoprotein ligand-1) plays a role in adenos
58 pendent of the mucin-like molecules CD43 and P-selectin glycoprotein ligand-1, previously implicated
59 ECA-452-reactive and nonreactive isoforms of P-selectin glycoprotein ligand 1 (PSGL-1) and can tether
64 ocytophilum are linked to bacterial usage of P-selectin glycoprotein ligand 1 (PSGL-1) as a receptor
66 ospholipid antibodies, neutrophils clustered P-selectin glycoprotein ligand 1 (PSGL-1) by cortical ac
67 d with neutrophil activation, rolling ligand P-selectin glycoprotein ligand 1 (PSGL-1) expression, as
70 residues in the leukocyte adhesion molecule P-selectin glycoprotein ligand 1 (PSGL-1) is required fo
72 cule 1 failed to ameliorate ileitis, whereas P-selectin glycoprotein ligand 1 (PSGL-1) neutralization
73 ding of P-selectin on activated platelets to P-selectin glycoprotein ligand 1 (PSGL-1) on the microvi
75 nine, and interleukin 15, adhesion molecules P-selectin glycoprotein ligand 1 (PSGL-1), intercellular
76 e many candidate ligands for selectins, only P-selectin glycoprotein ligand 1 (PSGL-1), which also ac
78 ce probe to test the leukocyte adhesion bond P-selectin glycoprotein ligand 1 (PSGL-1)-P-selectin, we
87 mic endothelial cells and lost expression of P-selectin glycoprotein ligand 1 (PSGL-1, CD162) and L-s
88 tion of T cells marked by down-regulation of P-selectin glycoprotein ligand 1 (PSGL-1; also known as
89 king antibodies against either P-selectin or P-selectin glycoprotein ligand-1 (PSGL-1) alone inhibite
90 selectin ligands are expressed on human HCs, P-selectin glycoprotein ligand-1 (PSGL-1) and a speciali
91 to human neutrophils requires expression of P-selectin glycoprotein ligand-1 (PSGL-1) and alpha1-3-f
92 CLA epitope on T cells has been described on P-selectin glycoprotein ligand-1 (PSGL-1) and associated
93 etween oligosaccharides from human leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) and from zona
96 antigen-1, and CXCR4 but lower expression of P-selectin glycoprotein ligand-1 (PSGL-1) and of L-selec
97 eshold shear to support leukocyte rolling on P-selectin glycoprotein ligand-1 (PSGL-1) and other vasc
100 lection fluorescence/epi intensity, and that P-selectin glycoprotein ligand-1 (PSGL-1) and the integr
102 face expression of CXCR2 and less pronounced P-selectin glycoprotein ligand-1 (PSGL-1) begin to incre
104 glycosulfopeptide binding site (2-GSP-6) on P-selectin glycoprotein ligand-1 (PSGL-1) but not for a
106 the off-rate of P-selectin interacting with P-selectin glycoprotein ligand-1 (PSGL-1) decreased with
107 ed antigen (CLA), a specialized glycoform of P-selectin glycoprotein ligand-1 (PSGL-1) defined by mon
108 this study, we show that mice deficient for P-selectin glycoprotein ligand-1 (PSGL-1) develop a more
109 L-selectin interacts with the dimeric mucin P-selectin glycoprotein ligand-1 (PSGL-1) expressed on l
110 n a shear field via bonding of L-selectin to P-selectin glycoprotein ligand-1 (PSGL-1) followed by a
111 (X) (sialyl-Lewis-X) epitope is expressed in P-selectin glycoprotein ligand-1 (PSGL-1) from neutrophi
113 lectin-ligand at the N terminus of leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) in humans and
114 blockade of P- and E-selectins by a soluble P-selectin glycoprotein ligand-1 (PSGL-1) in rat models
115 sphorylated myosin L chain, flotillin-2, and P-selectin glycoprotein ligand-1 (PSGL-1) in the uropod.
117 erminus as an extension of membrane-anchored P-selectin glycoprotein ligand-1 (PSGL-1) inhibited inte
118 inhibited by anti-P-selectin aptamer or anti-P-selectin glycoprotein ligand-1 (PSGL-1) inhibitory ant
132 we found that the E-selectin-binding form of P-selectin glycoprotein ligand-1 (PSGL-1) is expressed o
134 uggested that glycosylation and sulfation of P-selectin glycoprotein ligand-1 (PSGL-1) is required fo
135 Dissociation of bonds between L-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) loaded at a co
136 re mediated through binding of P-selectin to P-selectin glycoprotein ligand-1 (PSGL-1) located on the
137 P-selectin monoclonal antibody (mAb) or anti-P-selectin glycoprotein ligand-1 (PSGL-1) mAb would redu
138 prevention of platelet-leukocyte binding via P-selectin glycoprotein ligand-1 (PSGL-1) may be benefic
145 while P-selectin interacts exclusively with P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes.
146 we focused on adhesion dynamics that involve P-selectin glycoprotein ligand-1 (PSGL-1) on MM cells an
147 dhesion receptor L-selectin forms bonds with P-selectin glycoprotein ligand-1 (PSGL-1) on other leuko
148 ated platelets through a mechanism involving P-selectin glycoprotein ligand-1 (PSGL-1) on the microve
150 d P- and L-selectin to their natural ligand, P-selectin glycoprotein ligand-1 (PSGL-1) over the predi
152 endothelium express P-selectin, which binds P-selectin glycoprotein ligand-1 (PSGL-1) that is expres
156 bond formation rates on their common ligand P-selectin glycoprotein ligand-1 (PSGL-1) under shear fl
157 ics of selectins (P-, L-, and E-selectin) to P-selectin glycoprotein ligand-1 (PSGL-1) via computatio
159 an in vitro flow model and a blocking mAb to P-selectin glycoprotein ligand-1 (PSGL-1) were used to d
160 ts on sialyl Lewis X expression displayed by P-selectin glycoprotein ligand-1 (PSGL-1) with sialylate
161 We tested the hypothesis that deficiency of P-selectin glycoprotein ligand-1 (Psgl-1) would improve
164 is an inducible carbohydrate modification of P-selectin glycoprotein ligand-1 (PSGL-1), a known surfa
165 P-selectin binds to the N-terminal region of P-selectin glycoprotein ligand-1 (PSGL-1), a mucin on le
166 L-selectin bind to the N-terminal region of P-selectin glycoprotein ligand-1 (PSGL-1), a mucin on le
169 enge increase on blood or BAL eosinophils of P-selectin glycoprotein ligand-1 (PSGL-1), a receptor fo
171 id adhesion of beads coated with recombinant P-selectin glycoprotein ligand-1 (PSGL-1), an E-selectin
172 we showed that E-selectin ligand-1 (ESL-1), P-selectin glycoprotein ligand-1 (PSGL-1), and CD44 enco
173 neutrophils roll on P- or E-selectin, engage P-selectin glycoprotein ligand-1 (PSGL-1), and signal ex
174 ophils is linked to neutrophil expression of P-selectin glycoprotein ligand-1 (PSGL-1), as well as si
175 electin binding to its physiological ligand, P-selectin glycoprotein ligand-1 (PSGL-1), both in cell
178 Ethanol (0.3% by volume) had no effect on P-selectin glycoprotein ligand-1 (PSGL-1), L-selectin, o
179 and its leukocyte ligand, a homodimer termed P-selectin glycoprotein ligand-1 (PSGL-1), mediate the e
180 gated the function of the adhesion molecule, P-selectin glycoprotein ligand-1 (PSGL-1), that is upreg
182 do not generate microthrombi in mice lacking P-selectin glycoprotein ligand-1 (PSGL-1), the leukocyte
184 pressing PMPs bridge leukocytes that express P-selectin glycoprotein ligand-1 (PSGL-1), thereby allow
185 lities of selectins and the selectin ligand, P-selectin glycoprotein ligand-1 (PSGL-1), to support te
186 e predominant leukocyte L-selectin ligand is P-selectin glycoprotein ligand-1 (PSGL-1), which display
187 P-selectin blockade is completely absent in P-selectin glycoprotein ligand-1 (PSGL-1)-/- mice or wil
188 intravascular neutrophils through P-selectin/P-selectin glycoprotein ligand-1 (PSGL-1)-mediated bindi
201 rophage adherence promoted signaling through P-selectin glycoprotein ligand-1 (PSGL-1)/Akt/mTOR that
202 minus of the leukocyte cell-surface molecule P-selectin glycoprotein ligand-1 (PSGL-1, CD162) are imp
203 ar adhesion molecule-1 (ICAM-1, CD54), CD44, P-selectin glycoprotein ligand-1 (PSGL-1, CD162), cytoki
204 gulant microparticles in human blood through P-selectin glycoprotein ligand-1 (PSGL-1; encoded by the
205 inistration of a recombinant soluble form of P-selectin glycoprotein ligand-1 (PSGL-1; the recombinan
206 on in vivo and on P-selectin in vitro, where P-selectin-glycoprotein-ligand-1 (PSGL-1) is found in di
207 eously express functional rolling machinery (P-selectin glycoprotein ligand-1 [PSGL-1] and Sialyl-Lew
209 to mouse neutrophils, this was dependent on P-selectin glycoprotein ligand 1 (PSGL1), alpha(L)beta(2
210 erized by a Bcl6-dependent downregulation of P-selectin glycoprotein ligand 1 (PSGL1, a CCL19- and CC
211 ced synthesis of C2-O-sLe(x) associated with P-selectin glycoprotein ligand-1, reduced cell tethering
212 d the lifetimes of P-selectin complexes with P-selectin glycoprotein ligand-1, revealing both catch a
213 teraction with its leukocyte ligand, PSGL-1 (P-selectin glycoprotein ligand 1), the interaction with
214 cking molecules, including CCR9, L selectin, P selectin glycoprotein ligand-1, the integrin subunits
215 singly, however, donor T cells deficient for P-selectin glycoprotein ligand 1, the most well describe
216 y use multiple P-selectin ligands apart from P-selectin glycoprotein ligand 1 to interact with P-sele
217 nd that eosinophils and neutrophils both use P-selectin glycoprotein ligand-1 to form stable conjugat
218 trafficking is dependent upon the binding of P-selectin glycoprotein ligand-1 to P- and E-selectin on
219 amed endothelium in vivo and cooperates with P-selectin glycoprotein ligand-1 to recruit neutrophils
220 t caNFATc1 enhances expression of functional P-selectin glycoprotein ligand-1, up-regulates Fas ligan
221 Tregs, forming the Sialyl Lewis X moiety on P-selectin glycoprotein ligand-1, would improve their tr